Ezetimibe, a vital component of Loncom Pharma's Cardiovascular APIS, addresses cholesterol management, improving heart health and overall patient well-being.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
